Compute Health Acquisition Corp.
CPUH · NYSE
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC from Compute Health Sponsor LLC, listed on NYSE in February 2021.
- What it's doing now
- It agreed in July 2023 to buy Allurion Technologies, Inc., an intragastric balloon weight loss devices company. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- Allurion Technologies, Inc.
- Industry
- Health Care — intragastric balloon weight loss devices
- Deal value
- not stated in the filings we hold
- announced 7 July 2023
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 8 February 2021
- size not on file · 100.0% of each $10 unit into trust
- Headquarters
- 1105 NORTH MARKET STREET, WILMINGTON, DE, 19890
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- Watanabe Gwendolyn A (Director) · Harsh Michael (Director) · ISHRAK OMAR (Chairman)
- Listed securities
- CPUH common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
2 dated milestonesEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 8 February 2021IPOpassed
IPO size not on file
- 7 July 2023Deal announcedpassed
Combination with Allurion Technologies, Inc.
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- Allurion Technologies, Inc.— · announced 7 July 2023closedHealth Carepost-close ALURSEC primary
The score
deterministic, from filed fieldsCPUH is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
Compute Health Acquisition Corp. (NYSE: CPUH) was a blank-check company whose IPO was priced on February 8, 2021, according to a 424B prospectus. The company's SEC filings list CIK 0001828608 and SIC industry code 6770. Its securities included Class A common stock, units each consisting of one share of Class A common stock and one-quarter of one redeemable warrant, and redeemable warrants each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50. The common ticker CPUH appears on the cover page of an 8-K filed on July 28, 2023. The vehicle completed a business combination and is closed, with Form 25 filed on August 2, 2023, under 17 CFR 240.12d2-2(a)(3), after the shares came to evidence other securities in substitution therefor. The successor registrant, Allurion Technologies, Inc. (ALUR, ALUR-WT; CIK 0001964979), filed an 8-K carrying item 2.01, Completion of Acquisition, naming Compute Health Acquisition Corp.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
An 89.31% redemption of the Class A shares at the prior vote means the trust has already been reduced by nearly nine tenths, so Compute Health brings very little cash to Allurion and the combined company will depend on other financing. For the roughly 10% of Class A holders who stayed, this three-month extension is the last gate before the deal vote, and their redemption right at pro rata trust value remains intact. The scale of the earlier exodus is also the market's verdict on the transaction, delivered before the deal proxy was even circulated.
A target that must raise at least $15 million in private placements alongside the combination is signalling that trust cash alone will not fund it, and each successive convertible note round dilutes the equity CPUH holders would receive. The sponsor recapitalizing its founder shares and warrants usually means giving up some promote to keep the deal alive, which is a modest positive. Redemption at trust value remains the alternative to funding a business that still needs outside capital at closing.
At $867.1 million this is one of the largest trusts still intact at an extension vote, so the per-share floor is fully funded and redemption is a clean cash exit for anyone unwilling to take Allurion equity. The redemption limitation proposal removes the $5,000,001 net tangible asset guardrail, allowing that trust to be drawn down without any cap over the six-month extension. Holders who elect redemption and then have shares returned retain the right to redeem again if no combination closes by February 9, 2023.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
Show the other 10 filings
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
Compute Health Sponsor LLCnamed as sponsor in this SPAC’s filings — but with no researched track record behind it yet.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1284 tracked SPACs (23%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
Unit: U = S + W · 100.0% of the $10 unit
from 424B4 0001213900-21-007315
Trading & liquidity
Company profile
Directors & officers
- Watanabe Gwendolyn ADirector
- Harsh MichaelDirector
- ISHRAK OMARChairman
- Nehme JeanCo-CEO
- Fink Joshua ACo-CEO, CFO
- Barhoush HaniDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
4 filers with a stake on file · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- Compute Health Sponsor LLCwith 3 other reporting persons on the same schedule19.9% · SC 13GFeb 14, 2022 stale
- HGC Investment Management Inc.8.0% · SC 13GFeb 14, 2022 stale
- PUBLIC INVESTMENT FUND0.0% · SC 13G/AFeb 14, 2023 stale
- ARISTEIA CAPITAL LLC0.0% · SC 13G/AFeb 10, 2023 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
38 full SEC filing texts archived — searchable, never lost.
- Vault note — CPUH (Compute Health Acquisition Corp.)
vault-note · /vault/tickers/CPUH
- Vault deal note — Allurion Technologies, Inc. (CPUH)
vault-note · /vault/deals/allurion-technologies-inc
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail6 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from the HISTORICAL census (EDGAR's SIC 6770 registrant list, walked in full: 3,325 registrants, 1,167 of which ever priced an IPO). The live discovery job cannot reach this registrant — it reads the filing tape, and this one stopped filing. Admission rule: src/lib/universe-admit.ts. SIC 6770 (Blank Checks); 424B 0001213900-21-007315 priced 2021-02-08; common ticker CPUH off 8-K 0001193125-23-197815 (2023-07-28); lifecycle EXITED. Ending PROVEN, not inferred: CLOSED per Form 25 0000876661-23-000626 (2023-08-02) — Form 25 filed under 17 CFR 240.12d2-2(a)(3) — the rule for securities that "have come to evidence other securities in substitution therefor", i.e. the shares became the successor's (class: Class A Common Stock; Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant; Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50); the successor registrant ALLURION TECHNOLOGIES, INC. (ALUR, ALUR-WT) (CIK 0001964979) filed an 8-K carrying item 2.01 (Completion of Acquisition) naming "Compute Health Acquisition Corp." — the SPAC merged into a new registrant and so filed no closing report of its own. ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
sponsor "Compute Health Sponsor LLC" (SEC CIK 0001828596) sourced from Form 3 reportingOwner (10% owner) acc 0001213900-21-006923.
AI-extracted target (z-ai/glm-5.2, conf 0.95)
target recovered for a completed de-SPAC
entity created from the filed target name; no About paragraph on file, so every other field awaits a sourced read
OTHER -> BIOTECH, on DEFM14A 0001193125-23-183845: "successfully complete current and future preclinical studies and clinical trials of the Allurion Balloon and any other future product candidates;"